Saira Ramasastry insider trades: Mirum Pharmaceuticals (MIRM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Saira reports to the SEC
and 5 more companies
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MIRM | ↓ Sell | 3,977 | $100.00 | $398K | Direct | Jun 2, 2026 (1d) |
| May 15, 2026 | MIRM | ↓ Sell | 2,000 | $109.47 | $219K | Direct | May 18, 2026 (3d) |
| Apr 15, 2026 | MIRM | ↓ Sell | 2,000 | $96.90 | $194K | Direct | Apr 16, 2026 (1d) |
| Mar 16, 2026 | MIRM | ↓ Sell | 2,000 | $90.76 | $182K | Direct | Mar 17, 2026 (1d) |
| Feb 13, 2026 | MIRM | ↓ Sell | 2,000 | $102.09 | $204K | Direct | Feb 17, 2026 (4d) |
| Jan 15, 2026 | MIRM | ↓ Sell | 2,000 | $90.99 | $182K | Direct | Jan 16, 2026 (1d) |
| Dec 22, 2025 | MIRM | ↓ Sell | 5,000 | $80.00 | $400K | Direct | Dec 23, 2025 (1d) |
| Dec 18, 2025 | MIRM | ↓ Sell | 2,000 | $69.73 | $139K | Direct | Dec 19, 2025 (1d) |
| Jun 3, 2025 | MIRM | ↓ Sell | 8,203 | $46.06 | $378K | Direct | Jun 4, 2025 (1d) |
| Jun 21, 2024 | DAWN | ↓ Sell | 10,000 | $13.19 | $132K | Direct | Jun 21, 2024 (0d) |
| Jun 11, 2024 | VIR | ↓ Sell | 4,000 | $10.95 | $44K | Direct | Jun 12, 2024 (1d) |
| Jun 5, 2024 | MIRM | ↓ Sell | 5,000 | $25.68 | $128K | Direct | Jun 7, 2024 (2d) |
| Jun 1, 2023 | VIR | ↓ Sell | 3,500 | $25.67 | $90K | Direct | Jun 2, 2023 (1d) |
| Jul 11, 2022 | VIR | ↓ Sell | 5,000 | $30.00 | $150K | Direct | Jul 13, 2022 (2d) |
| May 24, 2022 | VIR | ↓ Sell | 1,687 | $23.82 | $40K | Direct | May 25, 2022 (1d) |
| May 19, 2021 | VIR | ↓ Sell | 10,000 | $43.73 | $437K | Direct | May 20, 2021 (1d) |
| Dec 17, 2020 | SGMO | ↓ Sell | 10,000 | $13.27 | $133K | Direct | Dec 18, 2020 (1d) |
| Feb 26, 2018 | SGMO | ↓ Sell | 9,450 | $24.88 | $235K | Direct | Feb 27, 2018 (1d) |
| Nov 17, 2017 | SGMO | ↓ Sell | 5,000 | $14.67 | $73K | Direct | Nov 21, 2017 (4d) |
| Feb 12, 2015 | SGMO | ↓ Sell | 10,000 | $15.00 | $150K | Direct | Feb 13, 2015 (1d) |
| Aug 8, 2014 | SGMO | ↓ Sell | 10,000 | $14.00 | $140K | Direct | Aug 12, 2014 (4d) |
| Jun 23, 2014 | SGMO | ↓ Sell | 5,550 | $15.53 | $86K | Direct | Jun 25, 2014 (2d) |
| Mar 17, 2014 | SGMO | ↓ Sell | 10,000 | $23.26 | $233K | Direct | Mar 17, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MIRM insiders
Open-market trades in the last 12 months
About Saira Ramasastry's insider trades
Saira Ramasastry is an insider at Mirum Pharmaceuticals (MIRM). Since Mar 17, 2014, Saira has reported no open-market purchases and 23 sales worth $4.4M on SEC Form 4. In the last 12 months: 8 sales ($1.9M).
Their filings also include grants and awards (56 filings), option exercises (22 filings), shares returned to the company (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.